about
Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian ScenarioThe Peter Brojde lung cancer centre: a model of integrative practice.PREDOMOS study, impact of a social intervention program for socially isolated elderly cancer patients: study protocol for a randomized controlled trial.A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancerPhysical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivors.How should we describe the benefits of palliative radiotherapy?Docetaxel in the management of ovarian cancer.Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing modelThe association between comorbidities and the quality of life among colorectal cancer survivors in the People's Republic of ChinaDistress and unmet needs during treatment and quality of life in early cancer survivorship: a longitudinal study of haematological cancer patients.Effectiveness of the HuCare Quality Improvement Strategy on health-related quality of life in patients with cancer: study protocol of a stepped-wedge cluster randomised controlled trial (HuCare2 study).Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy.Psychological interventions to improve the quality of life in Indian lung cancer patients: A neglected area.Determinants of quality of life among Malaysian cancer patients: a cross-sectional study
P2860
Q28075347-47412A45-C016-42B7-A746-928D4ACF249EQ30417605-16FDDD38-8311-468A-BB9E-DD614D895D5FQ33556256-1F02C93D-9214-428B-9A6F-7548BE480D35Q34967545-F8EDFD9C-851B-4F1C-BC81-E9451A397455Q35341196-705F199E-0A6B-470D-964E-2CB42318096FQ36089090-4A610CAA-3BBE-4D19-AC18-3000F81D071DQ36118370-10D65C4D-0D38-4549-8F0A-7E47702D2D68Q36804541-376BC7BA-0A2C-41C7-80F4-143EA50B8FFEQ36996565-89C98C5E-9DA3-4789-9B09-200BFB837EDDQ37020120-2AE2AF80-3363-4866-B040-2202E1E4BDECQ38612080-AC6A2B82-5535-402B-A384-5497B2C36893Q42376809-5B53D148-239A-4041-8814-80C85C0F887FQ42743222-8AAB85DB-AD7B-45FB-969D-6C0DA78F7C92Q53083078-5119FE59-B254-44F1-9B14-0ED055A55950Q58786459-C37D3017-CB56-429F-BDB2-C35C9B763E38
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Quality of life as a primary end point in oncology.
@ast
Quality of life as a primary end point in oncology.
@en
Quality of life as a primary end point in oncology.
@nl
type
label
Quality of life as a primary end point in oncology.
@ast
Quality of life as a primary end point in oncology.
@en
Quality of life as a primary end point in oncology.
@nl
prefLabel
Quality of life as a primary end point in oncology.
@ast
Quality of life as a primary end point in oncology.
@en
Quality of life as a primary end point in oncology.
@nl
P356
P1433
P1476
Quality of life as a primary end point in oncology.
@en
P2093
P356
10.1093/ANNONC/12.SUPPL_3.S3
P478
12 Suppl 3
P577
2001-01-01T00:00:00Z